These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Behavior of pulmonary radioactivity in patients exposed to endolymphatic radiotherapy with lipiodol F-I 131]. Bagliani G, Buraggi GL, De Vecchi A, Fava G. Tumori; 1967; 53(3):225-35. PubMed ID: 4293146 [No Abstract] [Full Text] [Related]
3. Body distribution of intralymphatically injected radioactive colloid and oil. Erjavec M, Hacek S, Havlicek M, Klanjscek G. Radiobiol Radiother (Berl); 1969; 10(4):571-8. PubMed ID: 4312058 [No Abstract] [Full Text] [Related]
7. [Intralymphatic treatment of lymph-node metastases with Lipiodol labeled with I-131, with special reference to malignant melanoma]. Edwards JM. Minerva Med; 1967 Dec 12; 58(99):4512-3. PubMed ID: 4295505 [No Abstract] [Full Text] [Related]
14. [Radiation-dosimetry studies after endolymphatic radionuclide therapy]. Pfannenstiel P. Med Welt; 1974 Jun 07; 25(23):1038-42. PubMed ID: 4369658 [No Abstract] [Full Text] [Related]
15. [Practical value of endolymphatic radiotherapy. Isotopic lymphography]. Guerin RA, Roy L, Ottenat P. Presse Med (1893); 1969 Dec 13; 77(53):1983-6. PubMed ID: 4312945 [No Abstract] [Full Text] [Related]